← Leaderboards
Justin Rodney Savage
Glycomira, Llc
$2,775,433
Attributed
$4,398,202
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2011–23$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,398,202 · 6
By mechanism
R44$2,483,018 · 2
SB1$1,295,160 · 1
R43$620,024 · 3
Top collaborators
- Glenn D Prestwich6 shared
- Maria E Ryan4 shared
- Thomas Preston Kennedy3 shared
- Won Yong Lee3 shared
- Narayanam Venkateswara Rao2 shared
- Ying Gu1 shared
- Siam Oottamasathien1 shared
- Alana L Welm1 shared
Most similar at Glycomira, Llc
Same institution · by research overlap
- Thomas Preston Kennedy$609,145
- Narayanam Venkateswara Rao$124,938
- Won Yong Lee$2,853,952
- Alana L Welm$9,642,442
- Abigail Pulsipher$2,897,859
Others in their field
Top investigators on “Glycosaminoglycans”
- Paul Wesley Noble · Yale University$13,911,946
- Jeffrey D Esko · University Of California San Diego$12,431,390
- Ram Sasisekharan · Massachusetts Institute Of Technology$11,638,620
- Catherine E. Costello · Boston University Medical Campus$11,185,716
- Robert J Linhardt · University Of Iowa$10,956,160
- Brian F Volkman · University Of Wisconsin Madison$10,535,969
Research focus
GlycosaminoglycansMediatingAnti-Inflammatory AgentsDoseTissuesInflammationPharmaceutical PreparationsInflammatoryLeadLeukocytesProductionIn VivoChronicAffectEthersAmericanRattusCanis FamiliarisAnti-InflammatoryAdvanced Glycosylation End ProductsBaseHyaluronic AcidClinical TrialsLigands
Grant awards (9)
Glycosaminoglycans to Treat and Prevent Radiation-Induced Oral Mucositis$200,442
SB1 · FY2023 · DE · contact PI
Glycosaminoglycans to Treat and Prevent Radiation-Induced Oral Mucositis$1,094,718
SB1 · FY2022 · DE · contact PI
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis$976,018
R44 · FY2022 · AI · contact PI
Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis$7,000
R44 · FY2015 · DE · contact PI
Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis$685,157
R44 · FY2014 · DE · contact PI
Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis$814,843
R44 · FY2013 · DE · contact PI
Novel Glycosaminoglycan Ethers for Prevention of Metastasis$210,000
R43 · FY2011 · CA · contact PI
Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis$210,000
R43 · FY2011 · DE · contact PI
Novel Glycosaminoglycan Derivatives for Treatment of Bladder Inflammation$200,024
R43 · FY2011 · DK · contact PI